At 4:00 a.m. on a mid-March morning, while most of the country was hunkering down due to the COVID-19 pandemic, Jennifer Huber began the long drive from her home in the Hudson Valley Region of New York to Boston. With her was her 14-year-old daughter, Emma Levine, who was suffering from excruciating headaches caused by … Read more
This post originally appeared on Vector, Boston Children’s Hospital’s blog. While the genetic mutations driving adult cancers can sometimes be targeted with drugs, most pediatric cancers lack good targets. That’s because their driving genetic alterations often create fusion proteins that aren’t easy for drugs to attack. “This is one reason why it is notoriously hard … Read more
“Amelia is an amazing and extremely bright girl who has faced her disease and treatment with tremendous courage,” says Steven DuBois, MD, MS, her oncologist at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center.
The revelation brings a surge of hope to the field of pediatric oncology, which has long been challenged to find new drugs against childhood cancers.